LifeStance director sells 20,441 shares at $12.23

LifeStance Health Group, Inc. director Teresa DeLuca reported a sale of common stock.

Rhea-AI Filing Summary

LifeStance Health Group, Inc. director Teresa DeLuca reported a sale of common stock. On 2026-08-13, she sold 20,441 shares of common stock at a reported price of $12.23 per share in a sale characterized as an open market or private transaction. Following this transaction, she directly holds 104,593 shares of LifeStance Health Group common stock.

Insider Trade Summary

Net Seller: 20,441 shares

Net Sell 1 txn

Insider DeLuca Teresa

Role Director

Sold 20,441 shs ($250K)

Type	Security	Shares	Price	Value
Sale	Common Stock	20,441	$12.23	$250K

Holdings After Transaction: Common Stock — 104,593 shares (Direct)

Key Figures

Shares sold: 20,441 shares Sale price per share: $12.23 per share Shares held after transaction: 104,593 shares

3 metrics

Shares sold 20,441 shares Common stock sold by director Teresa DeLuca on 2026-08-13

Sale price per share $12.23 per share Reported price for the 20,441 LFST shares sold

Shares held after transaction 104,593 shares Direct holdings of LifeStance Health Group common stock after the sale

Key Terms

open market, private transaction, Rule 10b5-1 trading plan

3 terms

open market financial

"Sale in open market or private transaction"

An open market is a system where buying and selling of goods, services, or financial assets happen freely without restrictions or special controls. For investors, it means they can trade assets easily and quickly, which helps determine fair prices based on supply and demand. This environment encourages transparency and competition, making it easier to buy or sell with confidence.

private transaction financial

"Sale in open market or private transaction"

A private transaction is the sale or transfer of securities, assets, or ownership stakes carried out directly between a small number of parties rather than on a public exchange. For investors it matters because these deals are less visible and often less liquid than public trades, so pricing can be harder to verify, the investment can be harder to sell quickly, and buyers or sellers may gain strategic advantages not available in open markets — like negotiated terms similar to a private garage sale versus a crowded marketplace.

Rule 10b5-1 trading plan regulatory

"Rule 10b5-1 trading plan checkbox for this filing was not checked"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did LifeStance Health Group (LFST) report for Teresa DeLuca?

Teresa DeLuca, a director of LifeStance Health Group (LFST), reported selling 20,441 shares of common stock on 2026-08-13 in a sale described as an open market or private transaction.

How many LifeStance Health Group (LFST) shares did Teresa DeLuca sell and at what price?

Teresa DeLuca sold 20,441 shares of LifeStance Health Group common stock at a reported price of $12.23 per share. The transaction was coded as a sale in an open market or private transaction.

How many LifeStance Health Group (LFST) shares does Teresa DeLuca hold after the reported sale?

After the reported sale, Teresa DeLuca directly holds 104,593 shares of LifeStance Health Group common stock. This post-transaction holding reflects her remaining direct ownership position as disclosed.

Was Teresa DeLuca’s LFST stock sale reported under a Rule 10b5-1 trading plan?

The Rule 10b5-1 trading plan checkbox for this filing was not checked. The disclosure does not indicate that the reported 20,441-share sale was executed pursuant to an affirmed Rule 10b5-1 trading plan.

What type of transaction code was used for Teresa DeLuca’s LFST stock sale?

The transaction used code S, described as a “Sale in open market or private transaction.” It involved 20,441 shares of LifeStance Health Group common stock at $12.23 per share on 2026-08-13.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/14/2026 - 05:48 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DeLuca Teresa

(Last) (First) (Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE ARIZONA 85251

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/13/2026		S		20,441	D	$12.23	104,593	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	By: /s/ Ryan Pardo, Attorney-in-Fact	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)